ArticleOsteoporosis and sarcopenia2018

Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis.

Takako Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.